Zobrazeno 1 - 10
of 138
pro vyhledávání: '"Ah, Banham"'
Autor:
Ah, Banham, Jm, Connors, Pj, Brown, Jl, Cordell, Ott G, Sreenivasan G, Pedro Farinha, Horsman DE, Rd, Gascoyne
Publikováno v:
Europe PubMed Central
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::6d9462e2d3e4b19fee7fce8677875326
http://europepmc.org/abstract/med/15709173
http://europepmc.org/abstract/med/15709173
Autor:
Alakonya H; Department of Oncology, Oxford Institute for Radiation Oncology, University of Oxford, Oxford, United Kingdom., Koustoulidou S; Department of Oncology, Oxford Institute for Radiation Oncology, University of Oxford, Oxford, United Kingdom., Hopkins SL; Department of Oncology, Oxford Institute for Radiation Oncology, University of Oxford, Oxford, United Kingdom., Veal M; Department of Oncology, Oxford Institute for Radiation Oncology, University of Oxford, Oxford, United Kingdom., Ajenjo J; Department of Oncology, Oxford Institute for Radiation Oncology, University of Oxford, Oxford, United Kingdom., Sneddon D; Department of Oncology, Oxford Institute for Radiation Oncology, University of Oxford, Oxford, United Kingdom.; Department of Chemistry, University of Oxford, Oxford, United Kingdom., Dias G; Department of Oncology, Oxford Institute for Radiation Oncology, University of Oxford, Oxford, United Kingdom., Mosley M; Department of Oncology, Oxford Institute for Radiation Oncology, University of Oxford, Oxford, United Kingdom., Baguña Torres J; Department of Oncology, Oxford Institute for Radiation Oncology, University of Oxford, Oxford, United Kingdom., Amoroso F; Department of Oncology, Oxford Institute for Radiation Oncology, University of Oxford, Oxford, United Kingdom., Anderson A; Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom; and., Banham AH; Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom; and., Cornelissen B; Department of Oncology, Oxford Institute for Radiation Oncology, University of Oxford, Oxford, United Kingdom; bart.cornelissen@oncology.ox.ac.uk.; Nuclear Medicine and Molecular Imaging, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2024 Oct 01; Vol. 65 (10), pp. 1626-1632. Date of Electronic Publication: 2024 Oct 01.
Autor:
Sheldon H; Cancer Research UK Molecular Oncology Laboratories Weatherall Institute of Molecular Medicine University of Oxford John Radcliffe Hospital Oxford UK., Zhang W; Nuffield Department of Women's & Reproductive Health, Women's Centre University of Oxford John Radcliffe Hospital Oxford UK., Bridges E; Cancer Research UK Molecular Oncology Laboratories Weatherall Institute of Molecular Medicine University of Oxford John Radcliffe Hospital Oxford UK., Ang KH; Cancer Research UK Molecular Oncology Laboratories Weatherall Institute of Molecular Medicine University of Oxford John Radcliffe Hospital Oxford UK., Lin S; Cancer Research UK Molecular Oncology Laboratories Weatherall Institute of Molecular Medicine University of Oxford John Radcliffe Hospital Oxford UK., Masiero M; Nuffield Division of Clinical Laboratory Sciences Radcliffe Department of Medicine John Radcliffe Hospital Oxford UK., Li D; Nuffield Division of Clinical Laboratory Sciences Radcliffe Department of Medicine John Radcliffe Hospital Oxford UK., Handford PA; Department of Biochemistry University of Oxford Oxford UK., Whiteman P; Department of Biochemistry University of Oxford Oxford UK., Fischer R; Nuffield Department of Medicine Target Discovery Institute Oxford University, NDM Research Building Oxford UK., Buffa F; Department of Oncology University of Oxford Churchill Hospital Oxford UK., Vatish M; Nuffield Department of Women's & Reproductive Health, Women's Centre University of Oxford John Radcliffe Hospital Oxford UK., Banham AH; Nuffield Division of Clinical Laboratory Sciences Radcliffe Department of Medicine John Radcliffe Hospital Oxford UK., Harris AL; Cancer Research UK Molecular Oncology Laboratories Weatherall Institute of Molecular Medicine University of Oxford John Radcliffe Hospital Oxford UK.
Publikováno v:
Journal of extracellular biology [J Extracell Biol] 2022 Aug 02; Vol. 1 (8), pp. e52. Date of Electronic Publication: 2022 Aug 02 (Print Publication: 2022).
Autor:
Sheldon H; Cancer Research UK Molecular Oncology Laboratories, University of Oxford, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford OX3 9DU, UK., Alexander J; The Breast Cancer Now Toby Robins Research Centre, Division of Breast Cancer Research, The Institute of Cancer Research, London SM2 5NG, UK., Bridges E; Cancer Research UK Molecular Oncology Laboratories, University of Oxford, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford OX3 9DU, UK., Moreira L; Cardiovascular Medicine, RDM John Radcliffe Hospital, Oxford OX3 9DU, UK., Reilly S; Cardiovascular Medicine, RDM John Radcliffe Hospital, Oxford OX3 9DU, UK., Ang KH; Cancer Research UK Molecular Oncology Laboratories, University of Oxford, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford OX3 9DU, UK., Wang D; Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, John Radcliffe Hospital, Oxford OX3 9DU, UK., Lin S; Cancer Research UK Molecular Oncology Laboratories, University of Oxford, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford OX3 9DU, UK., Haider S; The Breast Cancer Now Toby Robins Research Centre, Division of Breast Cancer Research, The Institute of Cancer Research, London SM2 5NG, UK., Banham AH; Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, John Radcliffe Hospital, Oxford OX3 9DU, UK., Harris AL; Cancer Research UK Molecular Oncology Laboratories, University of Oxford, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford OX3 9DU, UK.
Publikováno v:
International journal of molecular sciences [Int J Mol Sci] 2021 Oct 19; Vol. 22 (20). Date of Electronic Publication: 2021 Oct 19.
Autor:
Favara DM; Balliol College, University of Oxford, Oxford, OX1 3BJ, UK. df411@cam.ac.uk.; Department of Oncology and Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, OX3 7DQ, UK. df411@cam.ac.uk.; Cambridge University Hospitals NHS Foundation Trust and Department of Oncology, Cambridge University, Cambridge, CB2 0XZ, UK. df411@cam.ac.uk., Liebscher I; Rudolf Schönheimer Institute of Biochemistry, Department of Molecular Biochemistry, University of Leipzig, 04103, Leipzig, Germany., Jazayeri A; Heptares Therapeutics Ltd, Welwyn Garden City, AL7 3AX, UK.; OMass Therapeutics, Oxford, OX4 4GE, UK., Nambiar M; Heptares Therapeutics Ltd, Welwyn Garden City, AL7 3AX, UK.; Sosei Heptares, Cambridge, CB21 6DG, UK., Sheldon H; Department of Oncology and Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, OX3 7DQ, UK., Banham AH; Nuffield Division of Clinical Laboratory Science, Radcliffe Department of Medicine, University of Oxford, Oxford, OX3 9DU, UK., Harris AL; Department of Oncology and Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, OX3 7DQ, UK. adrian.harris@oncology.ox.ac.uk.
Publikováno v:
Scientific reports [Sci Rep] 2021 Apr 23; Vol. 11 (1), pp. 8870. Date of Electronic Publication: 2021 Apr 23.
Autor:
Trenevska I; Nuffield Division of Clinical Laboratory Science, Radcliffe Department of Medicine, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom., Anderson AP; Nuffield Division of Clinical Laboratory Science, Radcliffe Department of Medicine, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom., Bentley C; Nuffield Division of Clinical Laboratory Science, Radcliffe Department of Medicine, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom., Hassanali T; Nuffield Division of Clinical Laboratory Science, Radcliffe Department of Medicine, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom., Wiblin S; Nuffield Division of Clinical Laboratory Science, Radcliffe Department of Medicine, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom., Maguire S; Nuffield Division of Clinical Laboratory Science, Radcliffe Department of Medicine, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom., Pezzella F; Nuffield Division of Clinical Laboratory Science, Radcliffe Department of Medicine, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom., Banham AH; Nuffield Division of Clinical Laboratory Science, Radcliffe Department of Medicine, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom., Li D; Nuffield Division of Clinical Laboratory Science, Radcliffe Department of Medicine, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom.
Publikováno v:
PloS one [PLoS One] 2021 Apr 09; Vol. 16 (4), pp. e0249967. Date of Electronic Publication: 2021 Apr 09 (Print Publication: 2021).
Autor:
Felce SL; NDCLS, Radcliffe Department of Medicine, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom.; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom., Anderson AP; NDCLS, Radcliffe Department of Medicine, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom., Maguire S; NDCLS, Radcliffe Department of Medicine, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom., Gascoyne DM; NDCLS, Radcliffe Department of Medicine, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom., Armstrong RN; NDCLS, Radcliffe Department of Medicine, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom.; Genetics and Genome Biology Program, Haematology Section, Division of Haematology/Oncology, Department of Paediatrics, The Hospital for Sick Children, Toronto, ON, Canada.; The Marrow Failure and Myelodysplasia Program, Haematology Section, Division of Haematology/Oncology, Department of Paediatrics, The Hospital for Sick Children, Toronto, ON, Canada., Wong KK; Department of Immunology, School of Medical Sciences, Health, Universiti Sains Malaysia, Kota Bharu, Malaysia., Li D; NDCLS, Radcliffe Department of Medicine, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom., Banham AH; NDCLS, Radcliffe Department of Medicine, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom.
Publikováno v:
Frontiers in oncology [Front Oncol] 2020 Apr 03; Vol. 10, pp. 448. Date of Electronic Publication: 2020 Apr 03 (Print Publication: 2020).
Autor:
Giatromanolaki A; Department of Pathology, University Hospital of Alexandroupolis, Democritus University of Thrace, Alexandroupolis, Greece., Harris AL; Cancer Research UK, Molecular Oncology Laboratories, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK., Banham AH; Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, John Radcliffe Hospital, Oxford, OX3 9DU, UK., Contrafouris CA; 1st Cardiac Surgery Department, Onassis Cardiac Surgery Center, 17674, Athens, Greece., Koukourakis MI; Department of Radiotherapy/Oncology, University Hospital of Alexandroupolis, Democritus University of Thrace, Alexandroupolis, Greece. targ@her.forthnet.gr.
Publikováno v:
British journal of cancer [Br J Cancer] 2020 Apr; Vol. 122 (8), pp. 1205-1210. Date of Electronic Publication: 2020 Feb 18.
Autor:
Maestre L; Monoclonal Antibodies Core Unit, CNIO, Madrid, Spain., García-García JF; Department of Pathology, MD Anderson Cancer Center Madrid, Madrid, Spain., Jiménez S; Monoclonal Antibodies Core Unit, CNIO, Madrid, Spain., Reyes-García AI; Monoclonal Antibodies Core Unit, CNIO, Madrid, Spain., García-González Á; Monoclonal Antibodies Core Unit, CNIO, Madrid, Spain., Montes-Moreno S; Hospital Universitario Marqués de Valdecilla, Pathology Department, Santander, Spain., Arribas AJ; Università della Svizzera Italiana, Institute of Oncology Research, Bellinzona, Switzerland., González-García P; Histopathology Core Unit, CNIO, Madrid, Spain., Caleiras E; Histopathology Core Unit, CNIO, Madrid, Spain., Banham AH; Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom., Piris MÁ; Department of Pathology, Fundación Jiménez Díaz, CIBERONC, Madrid, Spain., Roncador G; Monoclonal Antibodies Core Unit, CNIO, Madrid, Spain.
Publikováno v:
PloS one [PLoS One] 2020 Feb 27; Vol. 15 (2), pp. e0229743. Date of Electronic Publication: 2020 Feb 27 (Print Publication: 2020).
Autor:
Favara DM; Balliol College, University of Oxford, Oxford OX1 3BJ, UK.; Department of Oncology, University of Oxford, Oxford OX3 7DQ, UK., Zois CE; Department of Oncology, University of Oxford, Oxford OX3 7DQ, UK., Haider S; Department of Oncology, University of Oxford, Oxford OX3 7DQ, UK.; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London SW7 3RP, UK., Pires E; Chemistry Research Laboratory, Department of Chemistry, University of Oxford, Oxford OX1 3TA, UK., Sheldon H; Department of Oncology, University of Oxford, Oxford OX3 7DQ, UK., McCullagh J; Chemistry Research Laboratory, Department of Chemistry, University of Oxford, Oxford OX1 3TA, UK., Banham AH; Nuffield Division of Clinical Laboratory Science, Radcliffe Department of Medicine, University of Oxford, Oxford OX3 9DU, UK., Harris AL; Department of Oncology, University of Oxford, Oxford OX3 7DQ, UK.
Publikováno v:
Metabolites [Metabolites] 2019 Nov 25; Vol. 9 (12). Date of Electronic Publication: 2019 Nov 25.